Featured Conference
Executive Forum: Maximizing the Effectiveness of Medical Liaison Team Capabilities
Developing Excellence in the Field
October 20-22, 2004 The Park Hyatt Hotel at the Bellevue, Philadelphia, PA
Visit the conference website for more information and to register.
In many organizations Medical Liaisons are pulling more weight than in recent times. Management is beginning to see the power position their Liaisons are in. MSLs are on the front line, they know what is going on from the clinical perspective, the physician perspective and the marketing perspective. The question is how do you optimize the talents and the position your liaisons are in without crossing the legal line.
This Executive Forum will give you strategies and seamless integration techniques for developing, growing and enhancing your Medical Liaison Teams. There are lessons to be learned at each level including integrating competitive intelligence and developing metrics that show quantifiable results.
The objective of this conference is to provide an open exchange of information through panel discussions, round tables and presentations for you to extract ideas, strategy, and tools to develop a team strategy or strengthen your existing team structure.
Successful MSL programs are broadening their functions and finding continuity throughout the organization. Whether you are looking to start an MSL program or enhance the existing department this Executive Forum is for you. I invite you to download the brochure to learn what the following leaders are willing to share with you.
- Blair Robertson, D.Phil, MBA – Abbott Laboratories
- Mario Sylvestri, PharmD Amylin Pharmaceuticals
- Alan Minsk, JD – Arnall Golden Gregory, LLP
- Molly Moyle, MED – AstraZeneca Pharmaceuticals
- Nancy Coddington, PhD Astra Zeneca Pharmaceuticals
- Rebecca Vermeulen – Eli Lilly & Company
- Arda Ural – Eyetech Pharmaceuticals
- Dirk Haasner, PhD, MPM- Lundbeck USA, Inc
- Sharon Schneider – Ortho-McNeil Pharmaceutical Inc
- Catherine Sass, MBA, PharmD-Procter & Gamble Pharmaceuticals
- Ramesh Bangalore, PhD – Protein Design Labs
- Machelle Manuel, PhD – Sanyko Pharma, Inc.
- Kenneth Robinson- Scios, Inc
- John A Ohman, PharmD – Solvay Pharmaceuticals, Inc.
- Erin Albert, RPH, MBA – Sepracor
- Larry Staubach, MD, MBA – Tap Pharmaceuticals
- Jeri L. Stewart – Abbott Laboratories
- Jerri Anne Johnson, MED – Abbott Laboratories
Visit the conference website for more information and to register.
